Summary

Fundamentals in the clinical management of intoxication due to smoke inhalation

Dueñas-Laita A, Burillo Putze G, Alonso JR, Bajo Bajo A, Climent García B, Corrales Magin E, Felices F, Ferrer Dufol A, Hernández Frutos MP, Nogué S, Puiguriguer Ferrando J


Affiliation of the authors

Unidad Regional de Toxicología Clínica. Hospital Universitario Río Hortega. Valladolid, Spain. Servicio de Urgencias. Hospital Universitario de Canarias. Tenerife, Spain. Unidad de Toxicología Clínica. Área de Urgencias. Hospital Clínic. Barcelona, Spain.

DOI

Quote

Dueñas-Laita A, Burillo Putze G, Alonso JR, Bajo Bajo A, Climent García B, Corrales Magin E, et al. Fundamentals in the clinical management of intoxication due to smoke inhalation. Emergencias. 2010;22:384-94

Summary

Intoxication due to smoke inhalation is the main cause of morbidity and mortality from

fires. Smoke is a mixture of carbon particles suspended in hot air containing toxic gases.

Carbon monoxide (CO) and cyanuric acid are the gases that are mainly responsible for

tissue anoxia. The clinical signs of intoxication due to smoke inhalation vary. They may

include eye irritation, sore throat, laryngeal stridor, dysphagia, soot in sputum, cough,

breathlessness, laryngeal spasm, bronchospasm, coronary syndrome, coma, hypoxemia,

lactic acidosis, cyanosis, and death. A finding of soot in the nostrils, mouth or sputum

suggests severe intoxication. Lactate dehydrogenase levels over 10 mmol/L are indicative

of cyanuric acid levels over 40 mmol/L. Pulse oximetry has represented an important

advance for diagnosis, examination, and follow-up in this setting. The possible need for

early intubation must be assessed and oxygen administration (at 100%) is essential. The

treatment of choice for cyanuric acid poisoning is hydroxocobalamin. This antidote must

be administered promptly whenever a patient has inhaled smoke (soot in mouth, throat

or sputum), shows neurologic signs (confusion, coma, agitation, convulsions), or has any

of the following signs: bradypnea, respiratory arrest, cardiac arrest, shock, hypotension,

lactate dehydrogenase over 8 mmol/L, or lactic acidosis. Thereafter, management will be

dictated by symptoms or complications.

 

More articles by the authors

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.